November 4, 2021
Maryland on track to surpass $2B in VC funding this year
By Giacomo Bologna November 03, 2021, Maryland is on track to top $2 billion worth…
November 4, 2021
Record Funding Invested in Montgomery County, Maryland Companies in 2021 Q1-Q3 — MCEDC
Rockville, Md. — Thus far in 2021, a record pace for initial public offerings (IPO),…
November 4, 2021
Six Up-and-Coming COVID-19 Vaccines
Since the start of the COVID-19 pandemic, the response from public health agencies, regulators, researchers,…
November 4, 2021
Gaitherburg’s Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study
GAITHERSBURG, MD, November 2, 2021 – Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company…
November 1, 2021
BHI EIR Feedback Day November 17th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth…
November 1, 2021
JuneBrain Moves to UM BioPark for Next Growth Phase | UM BioPark
BALTIMORE, MD, OCT. 29, 2021 – The University of Maryland BioPark (UM BioPark) today announced…
November 1, 2021
BioTalk Welcomes Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF)
Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss…
November 1, 2021
BioTalk Welcomes Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF)
Amritha Jaishankar, PhD, Executive Director, Maryland Stem Cell Research Fund (MSCRF), joins BioTalk to discuss…
November 1, 2021
MaxCyte Signs Strategic Platform License with Nkarta, Inc. to Advance Natural Killer Cell Therapy Programs
Nkarta to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the development of…